COMMUNIQUÉS West-GlobeNewswire

Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)
14/07/2025
Sanuwave is pleased to announce preliminary revenues of $10.1 million to $10.2 million for the second quarter ended June 30, 2025. This represents the highest Q2 quarterly revenues in Company history. Q2 2025 revenue [...]
Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
14/07/2025
PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, [...]
ASAP Dental Care Marks Milestone in Dental Implants with Over 9,600 Procedures Performed
14/07/2025
Jacksonville, FL, July 14, 2025 (GLOBE NEWSWIRE) -- ASAP Dental Care, a leading provider of dental implants in Jacksonville and across Northeast Florida, has achieved a significant milestone in its surgical operations [...]
Total Orthopedics and Sports Medicine Expands Multi-Specialty Spine and Orthopedic Care in New York
14/07/2025
Total Orthopedics and Sports Medicine delivers coordinated, patient-centered orthopedic care across 14 New York locations. With over 20 board certified physicians, including Dr. Dante Leven, the practice offers [...]
Kane Biotech to Present at Advanced Wound Care Summit USA
14/07/2025
WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that Kane Biotech’s Interim Chief Executive Officer, Dr. Robert Huizinga, will be [...]
Strength Training For Women: CrazyBulk Legal Steroid Alternatives Are Changing the Muscle Building Supplements Game
14/07/2025
Strength training for women evolves in 2025 as CrazyBulk supplements offer legal, female-friendly alternatives to anabolic steroids for safe muscle building. New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- [...]
Muscle Endurance: Bodybuilders Turn to CrazyBulk Natural Legal Steroids and BodyBuilding Supplements For Muscle Growth
14/07/2025
CrazyBulk leads 2025 with natural legal steroids built for endurance, recovery, and lean strength—no needles, no risks, just clean performance New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- As the fitness world [...]
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue
14/07/2025
ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy Inc. ( OTC: BLEG ), a diversified holdings company, today announced significant changes in its leadership structure and a strategic merger [...]
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
14/07/2025
Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet lab dependency, and [...]
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
14/07/2025
SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced that it has completed [...]
Ascentage Pharma Announces Pricing of Top-Up Placement
14/07/2025
ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage ” or the “ Company ”), a global biopharmaceutical company dedicated [...]
The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant
14/07/2025
CHICAGO, July 14, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the three recipients of the 2025 FSR Early Career Fellowship Grant : William Lippitt, PhD, (University of [...]
Strength Training For Women: CrazyBulk Legal Steroid Alternatives Are Changing the Muscle Building Supplements Game
14/07/2025
Strength training for women evolves in 2025 as CrazyBulk supplements offer legal, female-friendly alternatives to anabolic steroids for safe muscle building New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- [...]
Personal Health Data Finally Simplified: Meet Validic Sparks
14/07/2025
A generative AI service that translates patient-generated health data into meaningful summaries. Designed to support health tech apps, value-based care, health systems, and connected care teams. DURHAM, N.C., July 14, [...]
Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board
14/07/2025
Appointment aims to reinforce Bonus Biogroup's leadership at a pivotal moment as the company advances toward Phase 3 clinical trials for its two flagship therapies: BonoFill and MesenCure HAIFA, Israel, July 14, 2025 ( [...]
I-Mab to Present at the BTIG Virtual Biotechnology Conference
14/07/2025
ROCKVILLE, Md., July 14, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, [...]
Castle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025
14/07/2025
FRIENDSWOOD, Texas, July 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its [...]
Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET
14/07/2025
CAMBRIDGE, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced [...]
Celcuity Announces Issuance of New Patent for Gedatolisib that Extends Patent Exclusivity into 2042
14/07/2025
MINNEAPOLIS, July 14, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the issuance of U.S. Patent No [...]

Pages